Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell Line

By Shibata S.   Sato H.   Ota H.   Karube A.   Takahashi O.   Tanaka T.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Atypical Endometrial Hyperplasia Treatment with Progestogens and Gonadotropin-Releasing Hormone Analogues: Long-Term Follow-up

By Perez-Medina T.   Bajo J.   Folgueira G.   Haya J.   Ortega P.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite

Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer

By Anderson John  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 433-443

Future Medicine

Access to resources Recommend Favorite

Cell Cycle Arrest in Endometrial Carcinoma Cells Exposed to Gonadotropin-Releasing Hormone Analog

By Kim J.W.   Lee Y.S.   Kim B.K.   Park D.C.   Lee J.M.   Kim I.K.   Namkoong S.E.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 368-371

Elsevier

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite